JP2007526336A5 - - Google Patents

Download PDF

Info

Publication number
JP2007526336A5
JP2007526336A5 JP2007502061A JP2007502061A JP2007526336A5 JP 2007526336 A5 JP2007526336 A5 JP 2007526336A5 JP 2007502061 A JP2007502061 A JP 2007502061A JP 2007502061 A JP2007502061 A JP 2007502061A JP 2007526336 A5 JP2007526336 A5 JP 2007526336A5
Authority
JP
Japan
Prior art keywords
phenyl
trifluoromethyl
cyano
trifluoroethyl
cyclopropylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007502061A
Other languages
English (en)
Japanese (ja)
Other versions
JP4805909B2 (ja
JP2007526336A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/007245 external-priority patent/WO2005085185A1/en
Publication of JP2007526336A publication Critical patent/JP2007526336A/ja
Publication of JP2007526336A5 publication Critical patent/JP2007526336A5/ja
Application granted granted Critical
Publication of JP4805909B2 publication Critical patent/JP4805909B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007502061A 2004-03-03 2005-03-03 選択的アンドロゲン受容体モジュレーターとしてのアニリン誘導体 Expired - Lifetime JP4805909B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54979404P 2004-03-03 2004-03-03
US60/549,794 2004-03-03
PCT/US2005/007245 WO2005085185A1 (en) 2004-03-03 2005-03-03 Aniline derivatives as selective androgen receptor modulators

Publications (3)

Publication Number Publication Date
JP2007526336A JP2007526336A (ja) 2007-09-13
JP2007526336A5 true JP2007526336A5 (enExample) 2008-04-17
JP4805909B2 JP4805909B2 (ja) 2011-11-02

Family

ID=34919539

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007502061A Expired - Lifetime JP4805909B2 (ja) 2004-03-03 2005-03-03 選択的アンドロゲン受容体モジュレーターとしてのアニリン誘導体

Country Status (5)

Country Link
US (2) US7514470B2 (enExample)
EP (1) EP1725522B1 (enExample)
JP (1) JP4805909B2 (enExample)
ES (1) ES2523017T3 (enExample)
WO (1) WO2005085185A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004110978A2 (en) * 2003-06-10 2004-12-23 Smithkline Beecham Corporation 1-aminonaphthalenes as modulators of androgen, glucocorticoid, mineralocorticoid and progesterone receptors
WO2005000795A2 (en) * 2003-06-10 2005-01-06 Smithkline Beecham Corporation Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators
JP2008536868A (ja) * 2005-04-15 2008-09-11 スミスクライン・ビーチャム・コーポレイション シアノアリールアミン
WO2007065093A2 (en) * 2005-11-30 2007-06-07 Smithkline Beecham Corporation Pyrrolidineanilines
JP5102985B2 (ja) * 2006-07-18 2012-12-19 東ソ−・エフテック株式会社 含フッ素2級アミン化合物の製造方法
AU2007284161A1 (en) * 2006-08-09 2008-02-21 Smithkline Beecham Corporation Pyrrolidinone anilines as progesterone receptor modulators
JP5204438B2 (ja) * 2007-07-31 2013-06-05 東ソ−・エフテック株式会社 含フッ素アミン化合物の製造方法
US8268872B2 (en) 2008-02-22 2012-09-18 Radius Health, Inc. Selective androgen receptor modulators
BRPI0907844B8 (pt) 2008-02-22 2021-05-25 Radius Health Inc compostos e método para modular um receptor de andrógeno, processos de preparação e composição farmacêutica dos mesmos e seus usos
NZ588737A (en) * 2008-03-31 2012-05-25 Univ Columbia Methods of diagnosing, preventing and treating bone mass diseases
WO2009136629A1 (ja) * 2008-05-09 2009-11-12 あすか製薬株式会社 生活習慣病予防・治療剤
AT509045B1 (de) 2010-01-29 2011-06-15 Planta Naturstoffe Vertriebsges M B H Verbindungen zur behandlung von asthma bronchiale
JP5964756B2 (ja) 2010-02-04 2016-08-03 ラジウス ヘルス,インコーポレイテッド 選択的アンドロゲン受容体モジュレーター
PL2568806T3 (pl) 2010-05-12 2017-03-31 Radius Health, Inc. Schematy lecznicze
US8642632B2 (en) 2010-07-02 2014-02-04 Radius Health, Inc. Selective androgen receptor modulators
AU2011312490B2 (en) 2010-09-28 2015-06-25 Radius Pharmaceuticals, Inc. Selective androgen receptor modulators
ES2939940T3 (es) 2014-03-28 2023-04-28 Univ Duke Tratamiento del cáncer de mama utilizando moduladores selectivos de los receptores de estrógenos
US9421264B2 (en) 2014-03-28 2016-08-23 Duke University Method of treating cancer using selective estrogen receptor modulators
KR20190077607A (ko) * 2014-10-16 2019-07-03 지티엑스, 인코포레이티드 Sarm을 이용하는 비뇨기 장애의 치료 방법
WO2017223115A1 (en) 2016-06-22 2017-12-28 Radius Health, Inc. Ar+ breast cancer treatment methods
EP3565542B1 (en) 2017-01-05 2024-04-10 Radius Pharmaceuticals, Inc. Polymorphic forms of rad1901-2hcl
BR112020023136A2 (pt) 2018-05-14 2021-02-09 Nuvation Bio Inc. compostos de alvo de receptor de hormônio nuclear anticâncer
SG11202013177WA (en) 2018-07-04 2021-01-28 Radius Pharmaceuticals Inc Polymorphic forms of rad 1901-2hcl
US12441745B2 (en) 2019-02-12 2025-10-14 Radius Pharmaceuticals, Inc. Processes and compounds
CN113811333B (zh) 2019-05-14 2024-03-12 诺维逊生物股份有限公司 靶向抗癌核激素受体的化合物
EP4058464A1 (en) 2019-11-13 2022-09-21 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
EP4313991A1 (en) 2021-03-23 2024-02-07 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
WO2022235585A1 (en) 2021-05-03 2022-11-10 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5585198A (en) 1996-11-22 1998-06-10 Athena Pharmaceuticals, Inc. N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and ethods for inhibiting beta-amyloid peptide release and/or its synthesis
AU5354398A (en) 1996-11-22 1998-06-10 Elan Pharmaceuticals, Inc. N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions compri sing same, and methods for inhibiting beta-amyloid peptide release and/or it s synthesis by use of such compounds
US6569896B2 (en) * 2000-08-24 2003-05-27 The University Of Tennessee Research Corporation Selective androgen receptor modulators and methods of use thereof
US6506782B1 (en) * 1998-02-27 2003-01-14 Athena Neurosciences, Inc. Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ATE301642T1 (de) * 2000-06-06 2005-08-15 Warner Lambert Co Bicyclische cyclohexylamine und ihre verwendung als nmda-rezeptor antagonisten
CN1176905C (zh) * 2002-03-22 2004-11-24 清华大学 甘氨酸乙酯邻苯二腈及其合成方法与应用
WO2005000795A2 (en) * 2003-06-10 2005-01-06 Smithkline Beecham Corporation Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators

Similar Documents

Publication Publication Date Title
JP2007505164A5 (enExample)
CA2614529A1 (en) Pyridazinone derivatives as thyroid hormone receptor agonists
RU2005137175A (ru) Производные сложного эфира и амида 2-цианопропановой кислоты и способы их применения
JP2007502264A5 (enExample)
JP2011504485A5 (enExample)
JP2019537605A5 (enExample)
JP2004525179A5 (enExample)
JP2005508349A5 (enExample)
RU2009118254A (ru) Фенилацетамиды в качестве ингибиторов протеинкиназ
RU2009105179A (ru) Сульфониламинокарбонилпроизводные амидов холевой кислоты для применения в качестве иммуномодуляторов
RS52816B (sr) Derivati propionamida koji se koriste kao modulatori androgenih receptora
JP2014525425A5 (enExample)
JP2009541489A5 (enExample)
JP2003517035A5 (enExample)
JP2007500245A5 (enExample)
JP2005522438A5 (enExample)
JP2004533450A5 (enExample)
JP2010505881A5 (enExample)
JP2007533722A5 (enExample)
JP2010522710A5 (enExample)
JP2005539045A5 (enExample)
JP2021507896A5 (enExample)
JP2006516280A5 (enExample)
JP2004518658A5 (enExample)
JP2005500345A5 (enExample)